Bonomo Isabela Teixeira, Lisboa Patricia Cristina, Pereira Analaura Ribeiro, Passos Magna Cottini Fonseca, de Moura Egberto Gaspar
Departmento de Ciências Fisiológicas, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Av. 28 de setembro, 87 Rio de Janeiro, RJ, 20551-030, Brazil.
J Endocrinol. 2007 Feb;192(2):339-44. doi: 10.1677/joe.1.06952.
Maternal malnutrition during lactation reduces prolactin (PRL) and milk production, alters milk composition, and programs the body weight of the offspring. Our study aimed to evaluate the long-term effects of maternal hypoprolactinemia at the end of lactation on food ingestion, body weight, amount of retroperitoneal white adipose tissue (RPWAT), leptinemia, and anorectic leptin effect in the adult offspring. Lactating rats were treated with bromocriptine (BRO), a PRL inhibitor, 1 mg twice a day, or saline (C - control) for the last 3 days of lactation. The body weight and food intake were monitored, and after sacrifice at 180 days, the RPWAT was weighted. In a second experiment, the anorectic leptin effect was tested on 180-day-old animals. Adult offspring whose mothers were BRO-treated showed higher body weight (10%), higher amount of RPWAT (2 x 3 times), higher total body fat (+39%), and hyperleptinemia (2 x 9 times) when compared with C, although food intake did not alter. After injection of leptin, the food ingestion at 2, 4 and 6 h was unaffected in BRO animals, confirming a resistance to the anorectic effect of leptin. Since the maternal PRL inhibition during lactation programs, a higher body weight with no alteration of food ingestion, we suggest a hypometabolic state. The leptin anorectic resistance can be due to the hyperleptinemia. We suggest that PRL changes during lactation can regulate body weight during adulthood.
哺乳期母体营养不良会降低催乳素(PRL)水平和乳汁分泌量,改变乳汁成分,并影响后代的体重。我们的研究旨在评估哺乳期结束时母体低催乳素血症对成年后代食物摄取、体重、腹膜后白色脂肪组织(RPWAT)量、瘦素血症以及瘦素厌食作用的长期影响。在哺乳期的最后3天,给哺乳大鼠每天两次注射1 mg催乳素抑制剂溴隐亭(BRO),或注射生理盐水(C组 - 对照组)。监测体重和食物摄入量,在180天时处死动物后称量RPWAT的重量。在第二个实验中,对180日龄的动物测试瘦素的厌食作用。与C组相比,母亲接受BRO治疗的成年后代体重更高(高10%),RPWAT量更多(高2至3倍),全身脂肪总量更高(高39%),且瘦素血症水平更高(高2至9倍),尽管食物摄入量没有改变。注射瘦素后,BRO组动物在2、4和6小时时的食物摄取量未受影响,证实其对瘦素的厌食作用具有抗性。由于哺乳期母体催乳素抑制会导致体重增加而食物摄入量不变,我们认为这是一种低代谢状态。瘦素厌食抗性可能是由于高瘦素血症所致。我们认为哺乳期催乳素的变化可调节成年期的体重。